ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.405,64
-1,10%
S&P 500
5.291,34
0,15%
Dow Jones
38.711,29
0,36%
Euro vs US Dollar
1,08792
-0,25%
Bitcoin
70.675,00
2,72%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Intercept Pharmaceuticals Inc (ICPT)

  7. Intercept Pharmaceuticals Inc (ICPT) News

ICPT

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ICPT
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202414h00GlobeNewswire Inc.Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 ConferenceNASDAQ:ICPTIntercept Pharmaceuticals Inc
29/02/202414h30GlobeNewswire Inc.Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBCNASDAQ:ICPTIntercept Pharmaceuticals Inc
20/11/202318h09Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ICPTIntercept Pharmaceuticals Inc
15/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ICPTIntercept Pharmaceuticals Inc
15/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202320h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICPTIntercept Pharmaceuticals Inc
13/11/202314h00GlobeNewswire Inc.Intercept Announces New Phase 2 Data Showing Significant Impact of OCA-Bezafibrate Combination on Normalization of Multiple Key Biomarkers of PBC-Induced Liver Damage at AASLD The Liver Meeting® 2023NASDAQ:ICPTIntercept Pharmaceuticals Inc
10/11/202314h00GlobeNewswire Inc.Intercept Announces New Findings from Long-term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD The Liver Meeting® 2023NASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202322h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202322h28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202322h28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202322h26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202322h21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202322h21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202322h20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
08/11/202322h19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICPTIntercept Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ICPT

Kürzlich von Ihnen besucht

CCOM
US100
US Tech 100
NYSE
DIS
Walt Disney
TG
432
Arbor Metals
DBI
MDAX
MDAX
TG
DTE
Deutsche Telekom
TG
D7G
Nel ASA
TG
CBK
Commerzbank
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
PM
XAUUSD
Gold vs US Dollar
AMEX
SPY
SPDR S&P 500
NYSE
MRK
Merck
USOTC
ADDYY
Adidas (QX)
TG
BAYN
Bayer
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten